GlassScriptPhysician profile
Edwardo D Verzola
NPI 1245381201
$1,266.83
in general payments reported to CMS, 2019-2025
19 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $163 · 2021: $26.74 · 2022: $92.10 · 2023: $126 · 2024: $47.25 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $299.08 | 2019-2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $195.36 | 2019-2021 | |
| Abbvie INC. | $194.52 | 2019-2025 | Mavyret, Linzess, Creon |
| Phathom Pharmaceuticals, INC. | $119.06 | 2025 | Voquezna |
| Pfizer INC. | $53.23 | 2019-2022 | |
| Qol Medical, LLC | $48.53 | 2019 | |
| Shionogi INC | $47.84 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $39.39 | 2025 | Dupixent |
| Braintree Laboratories, INC. | $33.61 | 2019 | |
| Merck Sharp & Dohme LLC | $32.18 | 2019-2022 | |
| Gilead Sciences, INC. | $31.82 | 2019-2020 | |
| Capsovision, INC. | $28.29 | 2023 | Capsocam Plus |
| Ironwood Pharmaceuticals, INC | $26.70 | 2020 | |
| Nestle Healthcare Nutrition INC. | $24.72 | 2022 | |
| Pharmacosmos Therapeutics INC. | $24.44 | 2023 | Monoferric |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.37 | 2025 | Inceptiv |
| Organon LLC | $16.75 | 2025 | Renflexis |
| Micro-Tech Endoscopy USA, INC. | $16.64 | 2025 | Lesionhunter |
| Boston Scientific Corporation | $15.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwardo Verzola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.